EP2586796
Samsetningar og aðferðir til notkunar mótefna gegn sklerostín
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.10.2008EP published:
7.12.2016EP application number:
13151551.2
EP translation filed:
28.2.2017Grant published:
15.3.2017EPO information:
European Patent Register
Max expiry date:
9.10.2028Expiry date:
9.10.2026Next due date:
31.10.2026
Title:
Compositions and methods for use for antibodies against sclerostin
Timeline
Today
10.10.2008EP application
7.12.2016EP Publication
28.2.2017Translation submitted
15.3.2017Registration published
9.10.2026Expires
Owner
Name:
MEREO BIOPHARMA 3 LIMITEDAddress:
4th Floor, One Cavendish Place, W01G 0QF, London, GB
Inventor
Name:
Kneissel, MichaelaAddress:
Basel, CH
Name:
Halleux, ChristineAddress:
Dornach, CH
Name:
Hu, Shou-IhAddress:
New Providence, NJ, US
Name:
Diefenbach-Streiber, BeateAddress:
Windach, DE
Name:
Prassler, JosefAddress:
Germering, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
07118414Date:
12.10.2007Country:
EP
Number:
08151911Date:
25.2.2008Country:
EP
Number:
08161342Date:
29.7.2008Country:
EP
Classification
Categories:
C07K 16/18, C12N 15/13, C12N 15/63, A61K 31/663, A61K 39/395, G01N 33/68, A61K 45/06, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 12.12.2017
Expires: 9.10.2018
Payer: Árnason Faktor
Number: 11
Paid: 6.9.2018
Expires: 9.10.2019
Payer: Árnason Faktor
Number: 12
Paid: 9.9.2019
Expires: 9.10.2020
Payer: Árnason Faktor
Number: 13
Paid: 9.9.2020
Expires: 9.10.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 7.9.2021
Expires: 9.10.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.9.2022
Expires: 9.10.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 25.9.2023
Expires: 9.10.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 17.9.2024
Expires: 9.10.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 2.10.2025
Expires: 9.10.2026
Payer: Árnason Faktor ehf.